($) USD (Default)
  • ($) AUD
  • (€) EUR
  • ($) CAD
  • ($) NZD
  • (£) GBP

CJC-1295 no DAC Peptides

Buy CJC-1295 no DAC Peptides Online From Direct Sarms Ireland

CJC1295 No DAC is a growth hormone releasing hormone (GHRH) analog and is designed to stimulate the release of growth hormone from the pituitary gland. Research studies have shown that CJC-1295 No DAC has several potential benefits, including increased muscle growth, fat loss, improved bone density, and enhanced immune system function. Studies indicate it may also have neuroprotective properties and promote improved sleep patterns.

What is CJC-1295 no DAC?

CJC-1295 no DAC, also known as Modified GRF 1-29 peptide or tetrasubstituted GRF 1-29,  is a synthetic peptide with 29 amino acids that functions as a growth hormone-releasing hormone (GHRH) analogue.It is designed to stimulate the secretion of growth hormone (GH) from the pituitary gland, promoting several physiological effects, including enhanced protein synthesis, increased insulin release from the pancreas, and improved bowel motility and gastric function. This process contributes to better body composition and elevated overall energy levels.

Unlike its counterpart, CJC-1295 with drug affinity complex (DAC), CJC-1295 without DAC has a shorter half-life, resulting in a more immediate yet transient effect on GH secretion. This peptide is often researched for its potential therapeutic applications in conditions related to growth hormone deficiency and for facilitating muscle growth in healthy adults.

Use and administration of CJC-1295 no DAC should be conducted under professional guidance due to possible side effects, including nausea and other reactions.

How Does CJC-1295 no DAC Work?

CJC-1295 without DAC, or mod GRF, operates by mimicking the body’s natural growth hormone-releasing hormone (GHRH), binding to specific GHRH receptors located on the pituitary gland. This interaction triggers a cascade of intracellular events that culminate in the enhanced secretion of growth hormone (GH) into the bloodstream.

The increase in GH levels promotes several anabolic processes, such as heightened protein synthesis and improved muscle mass. The mechanism also involves the modulation of various endocrine pathways, affecting insulin-like growth factor 1 (IGF-1) production, which further contributes to its physiological effects.

Due to its rapid action and shorter half-life, CJC-1295 no DAC is often administrated in a manner that allows for more frequent dosing to maintain elevated GH levels, thereby maximising its potential benefits for researchers.

CJC-1295 no DAC Specifications

PubChem CID: 91976842

Molecular Formula: C152H252N44O42

Molecular Weight: 3367.9 g/mol

Sequence:
H-DL-Tyr-DL-Ala-DL-Asp-DL-Ala-DL-xiIle-DL-Phe-DL-xiThr-DL-Gln-DL-Ser-DL-Tyr-DL-Arg-DL-Lys-DL-Val-DL-Leu-DL-Ala-DL-Gln-DL-Leu-DL-Ser-DL-Ala-DL-Arg-DL-Lys-DL-Leu-DL-Leu-DL-Gln-DL-Asp-DL-xiIle-DL-Leu-DL-Ser-DL-Arg-NH2

View our CJC-1295 no DAC High-Performance Liquid Chromatography (HPLC) Certificate here.

CJC-1295 no DAC StructureSource: PubChem

What are the suggested research benefits of CJC-1295 no DAC Peptides?

  • Potential Therapeutic Applications: Research indicates possible uses in treating growth hormone deficiencies and related disorders.
  • Modulation of IGF-1 Production: Influences the levels of insulin-like growth factor 1, which plays a critical role in muscle growth and metabolic processes.
  • Shorter Half-Life for Immediate Effects: Offers a rapid onset of action, making it suitable for specific research protocols that require quick assessment of GH secretion.
  • Flexibility in Administration: Allows for more frequent dosing schedules to maintain elevated serum GH levels for sustained research outcomes.
  • Enhanced Protein Synthesis: CJC-1295 without DAC boosts protein synthesis, essential for muscle growth and post-exercise recovery. It elevates gh levels, promoting anabolic activity for muscle development and repair, enhancing performance and accelerating recovery. It also maintains muscle mass during weight loss or dieting, crucial for managing body composition. Its impact on protein synthesis highlights its potential clinical value.
  • Improved Body Composition: Ireland Research indicates that CJC-1295 without DAC significantly improves body composition by increasing lean muscle and reducing fat. It boosts growth hormone levels, promoting protein synthesis for muscle growth and strength, and mobilizes fat for energy, aiding in fat loss. Ongoing studies are exploring its potential for enhancing physical appearance and metabolic health.
  • Increased Energy Levels:Increased GH levels boost mitochondrial function and fat metabolism, enhancing physical performance and endurance. Ireland Studies indicate that healthy adults could experience increased energy, benefiting daily activities and workouts. Additionally, higher GH levels promote faster recovery and reduced fatigue, useful for research on intense physical training. This energy boost can also improve motivation and productivity in different life areas.
  • Enhanced Sleep Quality: CJC-1295 no DAC may also contribute to improved sleep quality. Growth hormone plays a role in regulating sleep, and increases in GH levels can promote deeper and more restorative sleep cycles. This improvement in sleep quality can further enhance recovery and overall well-being, making it a vital consideration for Ireland researchers studying intense physical training or injury recovery.
  • Enhanced cognitive function: Ireland Research indicates that growth hormone plays a key role in neurogenesis and synaptic plasticity, essential for learning and memory. Higher levels of this hormone could enhance cognitive abilities by supporting the growth and repair of neural tissues, improving mental clarity and focus. Furthermore, CJC-1295 no DAC may influence brain function through its effect on insulin-like growth factor 1 (IGF-1), which is crucial for cognitive health. Exploring how this peptide affects cognition is crucial, particularly in relation to aging and neurodegenerative diseases.
  • Potential Impact on Fertility: Emerging research indicates that CJC-1295 no DAC could impact reproductive health, particularly through growth hormone’s role in fertility. Higher GH levels may improve reproductive hormones, potentially boosting ovarian and testicular function. Also, changes in insulin-like growth factor 1 (IGF-1) could significantly affect fertility. Given growth hormone’s complex link to reproductive health, more research on CJC-1295 no DAC’s fertility effects is needed, especially for those with GH deficiencies or similar conditions.
  • Tissue Regeneration: CJC-1295 no DAC may promote tissue regeneration by increasing growth hormone availability, which is vital for cell repair and regeneration. Higher GH levels can aid in repairing damaged tissues like muscles, bones, and skin, supporting recovery from injuries and enhancing overall healing. This quality makes CJC-1295 no DAC a focus for research into its potential uses in regenerative medicine and recovery after surgeries or acute injuries.
  • Potential Impact on Immune Function: Ireland Studies indicate it might boost immune function by affecting growth hormone secretion. Higher GH levels are linked to better immune responses, activating cells like lymphocytes and macrophages. This could help the body fight infections and enhance health, especially in those with intense training schedules or weakened immune systems. Further research could clarify how this peptide improves immunity.

What CJC-1295 no DAC products are available?

Buy CJC-1295 no DAC and Ipamorelin Blend Nasal Spray

Ipamorelin and CJC-1295 No DAC Blend Nasal Spray

Buy CJC-1295 no DAC and Ipamorelin Blend Nasal Spray for clinical research from Ireland Direct Sarms, available in 15ml and 30ml bottles.

This blend is also offered in a 2.5mg vial and a pre-mixed 2mg pen.

You can also buy CJC-1295 No DAC and GHRP-6 Blend for research purposes to investigate their combined effects on growth hormone modulation and metabolic processes. This blend is available in a 2.5mg vial and 15ml and 30ml nasal sprays.

Additionally Direct Sarms Ireland also offers cjc-1295 no dac and hgh fragment 176-191 blend for sale. Buy CJC-1295 No DAC and HGH Fragment 176-191 Blend, a targeted peptide combination designed to enhance growth hormone release while promoting fat loss and metabolic health in research environments.

Potential Benefits of Ipamorelin and CJC-1295 No DAC Blend:

  • Comprehensive Data Collection: Combining these peptides allows Ireland researchers to obtain a wider range of data on growth hormone dynamics and its implications for health and performance.
  • Mechanistic Insights: The synergistic action provides deeper insights into the mechanisms of growth hormone release and its physiological effects when studied together.
  • Controlled Study Conditions: Researchers can design experiments with varied dosing schedules to directly compare the effects of the peptide blend to individual components, enhancing study rigor.
  • Targeted Applications: The blend may facilitate targeted investigations into specific areas of interest, such as muscle growth, fat metabolism, and cognitive function, allowing for more focused hypotheses.
  • Innovative Therapeutic Approaches: Studying the blend can lead to novel therapeutic strategies for conditions related to growth hormone deficiencies or other metabolic disorders.
  • Safety and Efficacy Evaluation: Researchers can assess the safety profile and efficacy of the combination compared to standard treatments, informing clinical practices in the future.
  • Advancements in Peptide Research: The combination encourages advancements in therapeutic peptide research, with potential implications for sports science and gerontology.
  • Potential for New Discovery: Ongoing studies may uncover previously unrecognised benefits or interactions, contributing to the evolving field of peptide-based therapies.

Potential benefits of CJC-1295 no DAC and GHRP-2 Peptide Stack:

  • Augmented Growth Hormone Secretion: The combination can lead to increased growth hormone levels, offering valuable data for studies on hormonal regulation.
  • Enhanced Muscle Tissue Repair: Ireland Researchers can observe the effects of the stack on muscle recovery, aiding in understanding protein synthesis pathways.
  • Metabolic Observations: The stack may promote fat loss, providing insights into metabolic adaptations and energy expenditure.
  • Effects on Sleep Patterns: Investigating the impact of this stack on sleep quality can further knowledge on the relationship between sleep and hormone levels.
  • Cognitive Function Analysis: The potential cognitive enhancements from the combination may provide an avenue to study brain health and performance.
  • Immune Function Studies: Exploration of immune responses can be beneficial in understanding the physiological effects of peptide blends on health.
  • Longitudinal Health Studies: Ireland Researchers can assess the long-term effects of CJC-1295 no DAC and GHRP-2, contributing to anti-aging and overall health discourse.
  • Performance Metrics: The combination can be evaluated in various performance settings, such as athletic or clinical research, to establish efficacy.
  • Understanding Dosage Responsiveness: Researching varied dosing regimens can yield insights on optimising peptide use for therapeutic benefits.

Buy CJC-1295 no DAC and GHRP-2 Peptide Stack

GHRP-2 and CJC-1295 No DAC

Buy CJC-1295 no DAC and GHRP-2 Peptide Stack for research from Direct Sarms Ireland. 

Direct SARMs Ireland also offers a stack with Hexarelin, a notable growth hormone secretagogue. You can buy CJC-1295 no DAC and Hexarelin peptide stack here. Hexarelin is a growth hormone secretagogue that activates the ghrelin receptor, boosting GH release and supporting cellular health and recovery. This combination enhances muscle growth, fat metabolism, and recovery times, making it a valuable choice for researchers exploring growth hormone dynamics and its health and performance applications.

Frequently Asked Questions (FAQ’s) about CJC-1295 no DAC Peptides

Where can I buy CJC-1295 no DAC peptide?

Buy CJC-1295 no DAC peptides from trusted suppliers like Direct SARMs Ireland for premium, 99% pure research-quality peptides crucial for scientific studies.

What is the half life of CJC-1295 without DAC?

The half-life of CJC-1295 no DAC is approximately 30 minutes to 1 hour when administered subcutaneously. This relatively short half-life is due to the absence of a drug affinity complex (DAC), which typically extends the duration of action for similar peptides. However, despite its brief half-life, CJC-1295 no DAC promotes sustained growth hormone release due to its action of mimicking growth hormone-releasing hormone (GHRH), allowing for prolonged effects on growth hormone levels in the bloodstream. Researchers should be mindful of this when planning the dosing schedule to maximise the peptide’s benefits.

What is the difference between CJC-1295 DAC and CJC-1295 no DAC?

CJC-1295 DAC (Drug Affinity Complex) and CJC-1295 No DAC are synthetic peptides that stimulate growth hormone release, but they differ in structure and pharmacokinetics. CJC-1295 DAC has a modification that extends its half-life, allowing for less frequent dosing and a sustained release of growth hormone, which is convenient for researchers who prefer administering fewer injections.

In contrast, CJC-1295 No DAC has a shorter half-life, leading to quicker clearance from the body and requiring more frequent administration to maintain elevated growth hormone levels. Both peptides aim to boost growth hormone secretion, but the choice between them may depend on individual preferences for dosing frequency and desired duration of effect.

What is the legal status of CJC-1295 no DAC?

The legal status of CJC-1295 no DAC varies worldwide. In the US, it is not FDA-approved for medical use but permitted for research. Similarly, in the UK and Europe, it’s available for research but not human use. In Australia, the TGA has classified it as an unregistered substance, making therapeutic use illegal without approval. Individuals should consult local laws and seek professional advice for compliance.

What are the benefits of CJC-1295 no DAC?

The benefits include increased muscle mass, improved fat loss, enhanced recovery and tissue regeneration, better sleep quality, increased energy levels, and potential improvements in cognitive function and immune response.

What are the side effects of CJC-1295 no DAC?

Potential side effects may include injection site reactions, water retention, and changes in mood. Long-term effects are still being studied, and researchers should closely monitor the health of their test subjects.

Further Reading

For more information, explore our latest blog posts dedicated to CJC-1295 no DAC peptides.

Buy CJC-1295 no DAC Peptides Today!

You can buy CJC-1295 no DAC for Ireland research which is available in a range of formulations including blends, stacks, nasal sprays and subcutaneous injections (e.g., peptide vials and pre-mixed pens). When considering to buy CJC-1295 no DAC, it is essential to source from reputable suppliers, such as Direct Sarms Ireland, to guarantee the peptide’s quality and integrity, which is vital for securing reliable and consistent research results.


Scientific References

[1] M Alba, D Fintini, A Sagazio, et al (2006) Once-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analog, normalizes growth in the GHRH knockout mouse – American Journal of Physiology, Endocrinology and Metabolism, 2006 Dec, Volume 291 (Issue 6), Pages E1290-4.

[2] L Jetté, R Léger, K Thibaudeau, et al (2005) Human growth hormone-releasing factor (hGRF)1-29-albumin bioconjugates activate the GRF receptor on the anterior pituitary in rats: identification of CJC-1295 as a long-lasting GRF analog – Endocrinology, 2005 Jul, Volume 146 (Issue 7), Pages 3052-8.

[3] S L Teichman, A Neale, B Lawrence, et al (2005) Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults – The Journal of Clinical Endocrinology and Metabolism, 2006 Mar, Volume 91 (Issue 3), Pages 799-805.

[4] M Ionescu and L A Frohman (2006) Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog – Journal of Clinical Endocrinology and Metabolism, 2006 Dec, Volume 91 (Issue 12), Pages 4792-7.

[5] L Sackmann-Sala, J Ding, L A Frohman, and J J Kopchick (2009) Activation of the GH/IGF-1 axis by CJC-1295, a long-acting GHRH analog, results in serum protein profile changes in normal adult subjects – Growth Hormone & IGF Research,Volume 19, Issue 6, December 2009, Pages 471-477.


ALL CONTENT AND PRODUCT INFORMATION AVAILABLE ON THIS WEBSITE IS FOR EDUCATIONAL PURPOSES ONLY.

DISCLAIMER: These products are intended solely as a research chemical only. This classification allows for their use only for research development and laboratory studies. The information available on our Direct Sarms website is provided for educational purposes only. These products are not for human or animal use or consumption in any manner. Handling of these products should be limited to suitably qualified professionals. They are not to be classified as a drug, food, cosmetic, or medicinal product and must not be mislabelled or used as such.